Chen Bin, head of finance of Hanbang Biotech, resigned In the first half of the year, the company's net profit was 2.2101 million

On December 3, Hanbang Bio (872294) issued an announcement that in accordance with the relevant provisions of the Company Law and the articles of association of the company, the company's first employee congress in 2021 was deliberated and approved on December 3, 2021: Zhang Tongjin was appointed as the company's employee representative supervisor, and the term of office was until the expiration date of the second board of supervisors, effective from December 3, 2021. The above-mentioned appointees hold 0 shares of the company's shares, accounting for 0% of the company's share capital, and are not the targets of joint disciplinary action for untrustworthiness.

In accordance with the relevant provisions of the Company Law and the Articles of Association of the Company, the eighth meeting of the second board of directors of the company deliberated and approved on December 3, 2021: Bi Xiaoliang was appointed as the head of finance of the company, and the term of office ended until the expiration date of the second board of directors, with effect from December 3, 2021. The above-mentioned appointees hold 0 shares of the company's shares, accounting for 0% of the company's share capital, and are not the targets of joint disciplinary action for untrustworthiness.

In accordance with the relevant provisions of the Company Law and the Articles of Association of the Company, the fifth meeting of the second session of the Board of Supervisors of the Company deliberated and approved on December 3, 2021: Lin Longqiu was appointed as the chairman of the Supervisory Board of the Company, and the term of office was until the expiration date of the second board of supervisors, effective from December 3, 2021. The above-mentioned appointees hold 0 shares of the company's shares, accounting for 0% of the company's share capital, and are not the targets of joint disciplinary action for untrustworthiness.

On December 2, 2021, the Board of Directors received the resignation report submitted by Chen Bin, head of finance, with effect from December 2, 2021. The above-mentioned resigned person holds 0 shares of the company's shares, accounting for 0% of the company's share capital. Not the target of joint disciplinary action for untrustworthiness, and continue to serve as a director or secretary of the board of directors of the company after resigning.

According to the understanding of the digging shell network, Lin Longqiu resigned from the position of employee representative supervisor of the company due to the transfer of his position, and in accordance with the relevant provisions of the Company Law and the articles of association of the company, Zhang Tongjin was elected as the company's employee representative supervisor.

Chen Bin resigned as the head of the company's finance for personal reasons, and appointed Bi Xiaoliang as the head of the company's finance in accordance with the relevant provisions of the Company Law and the articles of association of the company.

Bi Xiaoliang resigned as the chairman of the company's board of supervisors due to job transfer reasons, and in accordance with the relevant provisions of the Company Law and the articles of association of the company, Lin Longqiu was elected as the chairman of the company's board of supervisors.

Chen Bin resigned as head of finance for personal reasons. The resignation did not result in the number of members of the company's board of directors falling below the statutory minimum, the number of members of the company's board of supervisors falling below the statutory minimum, and the number of employee representative supervisors being less than one-third of the members of the board of supervisors.

The above appointment is in accordance with the provisions of the Company Law and the Articles of Association of the Company, and will not adversely affect the production and operation of the company.

Chen Bin's resignation as the head of finance will not adversely affect the company's production and operation. The company is grateful for the contribution made by Chen Bin to the development of the company during his tenure!

The company's 2021 semi-annual report shows that the company's net profit attributable to the shareholders of the listed company in the first half of 2021 was 2,210,055.78 yuan, a decrease of 45.63% over the same period last year.

According to the data of the shell network, Hanbang Bio is mainly engaged in the research and development, production and sales of biopolymer materials, and has the core technology of large-scale production of high molecular weight polysaccharide biomaterials by enzymatic synthesis methods.

This article originated from the digging shell network